Welltower (NYSE: HCN) is one of 26 public companies in the “Healthcare REITs” industry, but how does it weigh in compared to its competitors? We will compare Welltower to related companies based on the strength of its valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and risk.
Risk & Volatility
Welltower has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Comparatively, Welltower’s competitors have a beta of 0.50, meaning that their average share price is 50% less volatile than the S&P 500.
Institutional and Insider Ownership
85.9% of Welltower shares are owned by institutional investors. Comparatively, 84.2% of shares of all “Healthcare REITs” companies are owned by institutional investors. 0.2% of Welltower shares are owned by company insiders. Comparatively, 2.1% of shares of all “Healthcare REITs” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Welltower and its competitors revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Welltower||$4.19 billion||$2.05 billion||22.80|
|Welltower Competitors||$863.81 million||$523.61 million||39.76|
Welltower has higher revenue and earnings than its competitors. Welltower is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Welltower pays an annual dividend of $3.48 per share and has a dividend yield of 4.8%. Welltower pays out 108.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Healthcare REITs” companies pay a dividend yield of 5.1% and pay out 124.4% of their earnings in the form of a dividend. Welltower has raised its dividend for 7 consecutive years.
This table compares Welltower and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent ratings for Welltower and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Welltower presently has a consensus target price of $71.55, suggesting a potential downside of 2.26%. As a group, “Healthcare REITs” companies have a potential upside of 1.83%. Given Welltower’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Welltower has less favorable growth aspects than its competitors.
Welltower competitors beat Welltower on 8 of the 15 factors compared.
Welltower Inc. invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties. Its triple-net properties include independent living facilities, independent supportive living facilities (Canada), continuing care retirement communities, assisted living facilities, care homes with and without nursing (the United Kingdom), Alzheimer’s/dementia care facilities, long-term/post-acute care facilities and hospitals. Its outpatient medical properties include outpatient medical buildings.
Receive News & Ratings for Welltower Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower Inc. and related companies with MarketBeat.com's FREE daily email newsletter.